Tatum Roger P, Wong Jamie A, Figueredo Edgar J, Martin Valeria, Oelschlager Brant K
Department of Surgery, University of Washington, VA Puget Sound HCS, 1660 S. Columbian Way, s-112-gs, Seattle, WA 98108, USA.
J Gastrointest Surg. 2007 Nov;11(11):1403-9. doi: 10.1007/s11605-007-0293-x. Epub 2007 Sep 5.
Treatment for achalasia is aimed at the lower esophageal sphincter (LES), although little is known about the effect, if any, of these treatments on esophageal body function (peristalsis and clearance). We sought to measure the effect of various treatments using combined manometry (peristalsis) with Multichannel Intraluminal Impedance (MII) (esophageal clearance).
We enrolled 56 patients with Achalasia referred to the University of Washington Swallowing Center between January 2003 and January 2006. Each was grouped according to prior treatment: 38 were untreated (untreated achalasia), 10 had undergone botox injection or balloon dilation (endoscopic treatment), and 16 a laparoscopic Heller myotomy. The preoperative studies for 8 of the myotomy patients were included in the untreated achalasia group. Each patient completed a dysphagia severity questionnaire (scale 0-10). Peristalsis was analyzed by manometry and esophageal clearance of liquid and viscous material by MII.
Mean dysphagia severity scores were significantly better in patients after Heller Myotomy than in either of the other groups (2.0 vs. 5.3 in the endoscopic group and 6.5 in untreated achalasia, p < 0.05). Peristaltic contractions were observed in 63% of patients in the Heller myotomy group, compared with 40% in the endoscopic group and 8% in untreated achalasia (p < 0.05 for both treatment groups vs. untreated achalasia). Liquid clearance rates were significantly better in both treatment groups: 28% in Heller myotomy and 16% in endoscopic treatment compared to only 5% in untreated achalasia (p < 0.05). Similarly, viscous clearance rates were 19% in Heller myotomy and 11% in endoscopic treatment, vs. 2% in untreated achalasia (p < 0.05). In the subset of patients who underwent manometry/MII both pre- and postoperatively, peristalsis was observed more frequently postoperatively than in preop studies (63% of patients exhibiting peristalsis vs. 12%), as was complete clearance of liquid (35% of swallows vs. 14%) and viscous boluses (22% of swallows vs. 14%). These differences were not significant, however. In the patients who had a myotomy the return of peristalsis correlates with effective esophageal clearance (liquid bolus: r = 0.46, p = 0.09 and viscous bolus: r = 0.63, p < 0.05). There is no correlation between peristalsis and bolus clearance in the endoscopic treatment group.
With treatment Achalasia patients exhibit some restoration in peristalsis as well as improved bolus clearance. After Heller Myotomy, the return of peristalsis correlates with esophageal clearance, which may partly explain its superior relief of dysphagia.
贲门失弛缓症的治疗主要针对食管下括约肌(LES),然而对于这些治疗方法对食管体部功能(蠕动和清除功能)的影响(如果有影响的话)却知之甚少。我们试图通过联合测压法(测量蠕动)和多通道腔内阻抗法(MII)(测量食管清除功能)来评估各种治疗方法的效果。
我们纳入了2003年1月至2006年1月期间转诊至华盛顿大学吞咽中心的56例贲门失弛缓症患者。根据既往治疗情况将患者分组:38例未接受过治疗(未经治疗的贲门失弛缓症),10例接受过肉毒杆菌注射或球囊扩张治疗(内镜治疗),16例接受过腹腔镜下Heller肌切开术。肌切开术患者中有8例的术前研究被纳入未经治疗的贲门失弛缓症组。每位患者完成一份吞咽困难严重程度问卷(0 - 10分)。通过测压法分析蠕动情况,并通过MII分析液体和粘性物质的食管清除功能。
Heller肌切开术后患者的平均吞咽困难严重程度评分显著优于其他两组(分别为2.0分,内镜治疗组为5.3分,未经治疗的贲门失弛缓症组为6.5分,p < 0.05)。Heller肌切开术组63%的患者观察到蠕动收缩,内镜治疗组为40%,未经治疗的贲门失弛缓症组为8%(两个治疗组与未经治疗的贲门失弛缓症组相比,p均< 0.05)。两个治疗组的液体清除率均显著更好:Heller肌切开术组为28%,内镜治疗组为16%,而未经治疗的贲门失弛缓症组仅为5%(p < 0.05)。同样,粘性物质清除率在Heller肌切开术组为19%,内镜治疗组为11%,未经治疗的贲门失弛缓症组为2%(p < 0.05)。在术前和术后均接受测压/MII检查的患者亚组中,术后观察到蠕动的频率高于术前研究(63%的患者出现蠕动,术前为12%),液体完全清除的情况也是如此(35%的吞咽与术前的14%)以及粘性团块(22%的吞咽与术前的14%)。然而,这些差异并不显著。在接受肌切开术的患者中,蠕动的恢复与有效的食管清除功能相关(液体团块:r = 0.46,p = 0.09;粘性团块:r = 0.63,p < 0.05)。在内镜治疗组中,蠕动与团块清除之间没有相关性。
经过治疗,贲门失弛缓症患者的蠕动功能有一定恢复,团块清除功能也有所改善。Heller肌切开术后,蠕动的恢复与食管清除功能相关,这可能部分解释了其在缓解吞咽困难方面的优势。